Aerosol-Cell Exposure System Applied to Semi-Adherent Cells for Aerosolization of Lung Surfactant and Nanoparticles Followed by High Quality RNA Extraction
Overview
Authors
Affiliations
Objectives: In this work, we developed a comprehensive methodology for coating semi-adherent lung cells cultured at the ALI with aerosolized surfactant and subsequent dose-controlled exposure to nanoparticles (NPs). This protocol is optimized for subsequent transcriptomic studies.
Methods: Semi-adherent rat alveolar macrophages NR8383 were grown at the ALI and coated with lung surfactant through nebulization using the VITROCELL Cloud 6 System before being exposed to TiO NM105 NPs. After NP exposures, RNA was extracted and its quantity and quality were measured.
Results: The VITROCELL Cloud system allowed for uniform and ultrathin coating of cells with aerosolized surfactant mimicking physiological conditions in the lung. While nebulization of 57 μL of 30 mg/mL TiO and 114 μL of 15 mg/mL TiO nanoparticles yielded identical cell delivered dose, the reproducibility of dose as well as the quality of RNA extracted were better for 114 μL.
Inhalable Mucociliary-On-Chip System Revealing Pulmonary Clearance Dynamics in Nanodrug Delivery.
Lin K, Lin H, Yang C, Chu Y, Xie R, Wang C ACS Nano. 2025; 19(2):2228-2244.
PMID: 39772499 PMC: 11760172. DOI: 10.1021/acsnano.4c11693.
Gonzales-Huerta L, Williams T, Aljohani R, Robertson B, Evans C, Armstrong-James D bioRxiv. 2024; .
PMID: 39605594 PMC: 11601337. DOI: 10.1101/2024.11.15.615211.
Maaz A, Blagbrough I, De Bank P Mol Pharm. 2024; 21(3):1108-1124.
PMID: 38333983 PMC: 10915796. DOI: 10.1021/acs.molpharmaceut.3c00639.
Editorial for the Special Issue "Biological and Toxicological Studies of Nanoparticles".
Joubert O Nanomaterials (Basel). 2023; 13(13).
PMID: 37446483 PMC: 10343638. DOI: 10.3390/nano13131968.
A multiplex inhalation platform to model like aerosol delivery in a breathing lung-on-chip.
Sengupta A, Dorn A, Jamshidi M, Schwob M, Hassan W, De Maddalena L Front Pharmacol. 2023; 14:1114739.
PMID: 36959848 PMC: 10029733. DOI: 10.3389/fphar.2023.1114739.